Stay updated on Nivolumab Dose Optimization Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Dose Optimization Clinical Trial page.

Latest updates to the Nivolumab Dose Optimization Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.5.0; removed related topics Lung cancer and MedlinePlus Genetics, and deleted Revision: v3.4.3.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded Lung cancer to related topics and included related topic MedlinePlus Genetics. Updated site revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRemoved the Lung cancer topic label and the related topic MedlinePlus Genetics from the page.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded related topic sections: Lung cancer and MedlinePlus Genetics to the page for disease context. These changes provide quick access to disease-related information but do not alter the study data or trial details.SummaryDifference0.1%

- Check37 days agoChange DetectedAdded Revision: v3.4.2 to the page. Removed the previous government-funding notices and Revision: v3.4.1.SummaryDifference0.2%

- Check44 days agoChange DetectedAdded a site-wide government funding notice indicating potential delays and that the NIH Clinical Center is open, and updated the site version to Revision: v3.4.1. Removed the 'Lung cancer' topic and related topics (MedlinePlus Genetics) and dropped the older Revision: v3.4.0.SummaryDifference0.3%

Stay in the know with updates to Nivolumab Dose Optimization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Dose Optimization Clinical Trial page.